Anti-tumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo

被引：0
|
作者：
Ray, J. [1 ]
Ralff, M. [1 ]
Jhaveri, A. [2 ]
El-Deiry, W. [2 ]
机构：
[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Brown Univ, Women & Infants Hosp, Providence, RI USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.06.158
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
85
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [41] A phase 2 study of ONC201 in recurrent/refractory metastatic breast cancer and advanced endometrial carcinoma
    Gatti-Mays, Margaret E.
    Greer, Yoshimi
    Steinberg, Seth
    Soltani, Sanaz
    Collins, Julie
    Olson, Michelle
    Ojemuyiwa, Michelle
    Annunziata, Christina
    Lee, Jung-Min
    Nunes, Ana
    Lipkowitz, Stan
    Zimmer, Alexandra
    CANCER RESEARCH, 2018, 78 (04)
  • [42] The preclinical evaluation of TIC10/ONC201 as an anti-pancreatic cancer agent
    Zhang, Qiangbo
    Wang, Hong
    Ran, Lin
    Zhang, Zongli
    Jiang, Runde
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 476 (04) : 260 - 266
  • [43] Anti-Tumorigenic Activity of Sophoflavescenol against Lewis Lung Carcinoma In Vitro and In Vivo
    Jung, Hyun Ah
    Jin, Seong Eun
    Choi, Ran Joo
    Hung Tran Manh
    Kim, Yeong Shik
    Min, Byung-Sun
    Son, You Kyung
    Ahn, Bo Ra
    Kim, Byung-Woo
    Sohn, Hee Sook
    Choi, Jae Sue
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (12) : 2087 - 2099
  • [44] Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway
    Allen, Joshua E.
    Krigsfeld, Gabriel
    Patel, Luv
    Mayes, Patrick A.
    Dicker, David T.
    Wu, Gen Sheng
    El-Deiry, Wafik S.
    MOLECULAR CANCER, 2015, 14
  • [45] Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway
    Joshua E Allen
    Gabriel Krigsfeld
    Luv Patel
    Patrick A Mayes
    David T Dicker
    Gen Sheng Wu
    Wafik S El-Deiry
    Molecular Cancer, 14
  • [46] ROLE OF CLPP AND MITOCHONDRIAL METABOLISM IN THE ANTI-CANCER EFFECTS OF IMIPRIDONE ONC201 AND ONC206 IN GLIOBLASTOMA AND DIPG
    Foster, Scott
    Lee, Andrew
    Maranto, Cristina
    Allen, Joshua E.
    Lanier, Randall
    Sethna, Phiroze
    Prabhu, Varun V.
    NEURO-ONCOLOGY, 2022, 24 : 234 - 234
  • [47] Clinical activity of the selective DRD2 antagonist ONC201, an imipridone, in metastatic endometrial cancer (mEC).
    Rodriguez-Rodriguez, Lorna
    Mehnert, Janice M.
    Silk, Ann W.
    Chan, Nancy
    Malhotra, Jyoti
    Aisner, Joseph
    Saunders, Tracie
    Yu, Bangning
    Dickerson, Siobhan
    Tarapore, Rohinton
    Allen, Joshua E.
    Stogniew, Martin
    Oster, Wolfgang
    Kaufman, Howard
    Haffty, Bruce George
    Bertino, Joseph R.
    Stein, Mark N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] Synergistic combination therapy with ONC201 or ONC206, and enzalutamide or darolutamide in preclinical studies of castration-resistant prostate cancer
    Wu, Laura Jinxuan
    Pinho-Schwermann, Maximilian
    Zhou, Lanlan
    Zhang, Leiqing
    Huntington, Kelsey E.
    Malpass, Ryan
    Seyhan, Attila A.
    Carneiro, Benedito A.
    El-Deiry, Wafik S.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (12): : 6012 - 6036
  • [49] Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro
    Jones, Hannah M.
    Fang, Ziwei
    Sun, Wenchuan
    Clark, Leslie H.
    Stine, Jessica E.
    Tran, Arthur-Quan
    Sullivan, Stephanie A.
    Gilliam, Timothy P.
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (12): : 2478 - 2490
  • [50] Immunomodulatory activity of selective DRD2 antagonist ONC201, an imipridone, in metastatic endometrial cancer (mEC)
    Tarapore, Rohinton S.
    Prabhu, Varun V.
    Mok, Samuel C.
    Yeung, Chilam Au
    Rodriguez, Lorna
    Girda, Eugenia
    Mantia-Smaldone, Gina
    Bae-Jump, Victoria
    Lu, Guangrong
    Oster, Wolfgang
    Allen, Joshua E.
    CANCER RESEARCH, 2020, 80 (16)
12345